Amicus Therapeutics Inc (FOLD) Stock Price and News

Actionable insights straight to your inbox

DJIA, S&P, NASDAQ on the Rise as Consumer Confidence Remains High

Stocks were trading higher on Tuesday as all the major indices posted significant gains, with the Nasdaq leading the charge. Among the day’s big gainers were growth companies and biotechs,

3 MIN READ
04.29.2014

Amicus Therapeutics (FOLD) Spikes on Phase III Data for Fabry Disease Treatment

Shares in Amicus Therapeutics (FOLD) spiked on Tuesday following the news that its lead therapy, climbing over 20 percent after reporting success in Phase III trials of migalastat HCL in

3 MIN READ
04.29.2014

Stocks Under $10: Hold Rated Biomed/Genetics in the Medical Sector

At www.ValuEngine.com we show that the Medical sector 10.6% overvalued with the Medical Biomed / Genetics 12.3% overvalued. All 16 stocks in today’s table have complete ValuEngine data and have

3 MIN READ
02.28.2013

Amicus Therapeutics Receives Positive Results in Pompe Disease Study

After missing earlier this month on achieving a statistically significant response in a phase 3 study with partner GlaxoSmithKline (GSK) for migalastat HCl against Fabry disease that chopped their

2 MIN READ
01.4.2013

Equities Sector Coverage: Industrial Stocks Lead Another Day of Gains

Initial Jobless Claims were higher than expected in the latest week at 428,000. Remember that the Recessionary Threshold is 350,000. The Chicago PMI rose to a stronger than expected reading of

7 MIN READ
06.30.2011

DJIA, S&P, NASDAQ on the Rise as Consumer Confidence Remains High

Amicus Therapeutics (FOLD) Spikes on Phase III Data for Fabry Disease Treatment

Stocks Under $10: Hold Rated Biomed/Genetics in the Medical Sector

Amicus Therapeutics Receives Positive Results in Pompe Disease Study

Equities Sector Coverage: Industrial Stocks Lead Another Day of Gains

Sign up For our Newsletter

CHANNELS

ABOUT